In The News

At The Heart Of Life, At The Heart Of Precision - Get Pumped Up About Heart Health

December 26, 2019

At The Heart Of Life, At The Heart Of Precision - Get Pumped Up About Heart Health

Meril has become the first Indian company in the world to make the Transcatheter Aortic Valve Replacement (TAVR) therapy available for patients. The human heart has four valves that are synchronized to open and close according to the heart’s rhythm.

In The News

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations

December 25, 2019

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations

Background and Purpose Liquid embolic agents (LEAs) are the determinant tool for successful embolization of cranial arteriovenous shunts. There are few currently available LEAs.

In The News

MeRes100 BRS, the first bioresorbable vascular matrix to treat coronary artery disease

December 25, 2019

MeRes100 BRS, the first bioresorbable vascular matrix to treat coronary artery disease

MeRes100 BRS - the first thin-tip sirolimus releasing bioresorbable vascular matrix - shows positive long-term safety consistent with low cardiac event rates and zero matrix stent thrombosis for patients with coronary artery disease   

ABOUT

Founded in 2006, Meril is an India-based global medical device company that is dedicated to the innovation, design and development of novel, clinically relevant and state-of-the-art devices


LEARN MORE